ferric citrate has been researched along with sucrose in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Lederer, SR; Schmid, H | 1 |
| Jang, SM; Pai, AB; Wegrzyn, N | 1 |
| Kobayashi, M; Maruyama, I; Maruyama, K; Tatemichi, S; Yaguchi, A; Yonekubo, S | 1 |
| Ando, T; Ito, K; Minegishi, A; Nagano, N; Ogawa, T; Tsutsui, T | 1 |
| Covic, AC; Floege, J; Funk, F; Ketteler, M; Rastogi, A; Sprague, SM; Walpen, S | 1 |
| Li, W; Liao, X; Ou, J; Rao, J; Xue, C; Zhu, Y | 1 |
| Fujino, T; Kaburagi, N; Morimoto, K; Oya, M; Takemitsu, TY; Yamashita, N; Yoshida, T | 1 |
3 review(s) available for ferric citrate and sucrose
| Article | Year |
|---|---|
Novel iron-containing phosphate binders for treatment of hyperphosphatemia.
Topics: Animals; Carbonates; Clinical Trials as Topic; Drug Combinations; Ferric Compounds; Humans; Hyperphosphatemia; Iron; Lanthanum; Magnesium; Phosphates; Renal Insufficiency, Chronic; Sevelamer; Starch; Sucrose | 2015 |
Iron-based phosphate binders--a new element in management of hyperphosphatemia.
Topics: Animals; Drug Combinations; Ferric Compounds; Humans; Hyperphosphatemia; Medication Adherence; Phosphates; Renal Insufficiency, Chronic; Sevelamer; Sucrose | 2016 |
Using iron-based phosphate binders in phosphate reduction and anemia improvement in patients receiving dialysis: a meta-analysis of randomized controlled trials.
Topics: Anemia; Carbonates; Drug Combinations; Ferric Compounds; Humans; Hyperphosphatemia; Iron; Magnesium; Randomized Controlled Trials as Topic; Renal Dialysis; Starch; Sucrose; Treatment Outcome | 2021 |
4 other study(ies) available for ferric citrate and sucrose
| Article | Year |
|---|---|
Comparison of Phosphate Binding Capacities of PA21, A Novel Phosphate Binder, with those of other Phosphate Binders in vitro and in vivo.
Topics: Administration, Oral; Animals; Calcium Carbonate; Chelating Agents; Drug Combinations; Ferric Compounds; Hyperphosphatemia; Lanthanum; Male; Phosphates; Rats; Rats, Sprague-Dawley; Sevelamer; Sucrose | 2016 |
Phosphate Binders Derived from Natural Ores Contain Many Kinds of Metallic Elements Besides Their Active Ingredient Metals.
Topics: Calcium Carbonate; Chelating Agents; Drug Combinations; Ferric Compounds; Japan; Lanthanum; Metals; Phosphates; Polyamines; Sevelamer; Spectrophotometry, Atomic; Sucrose | 2018 |
Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammation.
Topics: Administration, Oral; Anemia; Animals; Drug Combinations; Female; Ferric Compounds; Inflammation; Iron; Iron Overload; Kinetics; Male; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sucrose; Tissue Distribution | 2020 |
Long-term efficacy and safety of iron-based phosphate binders, ferric citrate hydrate and sucroferric oxyhydroxide, in hemodialysis patients.
Topics: Drug Combinations; Ferric Compounds; Humans; Hyperphosphatemia; Iron; Phosphates; Renal Dialysis; Retrospective Studies; Sucrose | 2022 |